Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
Beth Ryalls, Monica Patel, Eric Sparkes, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116052-116052
Open Access | Times Cited: 9
The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons
Robert Kronstrand, Caitlyn Norman, Svante Vikingsson, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 4, pp. 634-652
Open Access | Times Cited: 49
Ciências Forenses: Aplicações Científicas na Criminalística
Samara Alves Testoni, Cláudio M. P. Pereira, Rafael Scorsatto Ortiz
Revista Brasileira de Criminalística (2025) Vol. 14, Iss. 1, pp. 77-77
Open Access
Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias
Jamie J. Manning, Hayley M. Green, Michelle Glass, et al.
Neuropharmacology (2021) Vol. 193, pp. 108611-108611
Closed Access | Times Cited: 30
Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
Ayat Zagzoog, Asher L. Brandt, Tallan Black, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Synthetic cannabinoid receptor agonists are monoamine oxidase‐A selective inhibitors
Sarah A. Hindson, Rachael Andrews, Michael J. Danson, et al.
FEBS Journal (2023) Vol. 290, Iss. 12, pp. 3243-3257
Open Access | Times Cited: 11
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
J S James, Jessica Thrush, Taher M. Yusufali, et al.
Drug and Alcohol Dependence (2025), pp. 112672-112672
Closed Access
Fatal Overdose with the Cannabinoid Receptor Agonists MDMB-4en-PINACA and 4F-ABUTINACA: A Case Report and Review of the Literature
Gábor Simon, Mónika Kuzma, Mátyás Mayer, et al.
Toxics (2023) Vol. 11, Iss. 8, pp. 673-673
Open Access | Times Cited: 10
In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs
Marie H. Deventer, Mattias Persson, Caitlyn Norman, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 6, pp. 616-628
Closed Access | Times Cited: 9
The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC–QTOF-MS and synthesized reference standards
Steven Baginski, Tobias Rautio, Lorna A. Nisbet, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 9, pp. 826-834
Open Access | Times Cited: 8
Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
Eric Sparkes, Elizabeth A. Cairns, Richard C. Kevin, et al.
RSC Medicinal Chemistry (2021) Vol. 13, Iss. 2, pp. 156-174
Open Access | Times Cited: 19
Quantifying the Kinetics of Signaling and Arrestin Recruitment by Nervous System G-Protein Coupled Receptors
Sam R.J. Hoare, Paul Tewson, Shivani Sachdev, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13
Differential cannabinoid‐like effects and pharmacokinetics of ADB‐BICA, ADB‐BINACA, ADB‐4en‐PINACA and MDMB‐4en‐PINACA in mice: A comparative study
Fenghua Zhou, Xiaoli Wang, Sujun Tan, et al.
Addiction Biology (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 2
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
A. J. Timmerman, Margot Balcaen, Vera Coopman, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Feature-Based Molecular Network for New Psychoactive Substance Identification: The Case of Synthetic Cannabinoids in a Seized e-Liquid and Biological Samples
Romain Magny, Bertrand Lefrère, Emmanuel Roulland, et al.
Journal of the American Society for Mass Spectrometry (2024) Vol. 35, Iss. 10, pp. 2276-2287
Closed Access | Times Cited: 2
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays
Katharina Elisabeth Grafinger, Marthe M. Vandeputte, Annelies Cannaert, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 7, pp. 1412-1429
Open Access | Times Cited: 17
Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice
Grant C. Glatfelter, John S. Partilla, Michael H. Baumann
Neuropsychopharmacology (2021) Vol. 47, Iss. 4, pp. 924-932
Open Access | Times Cited: 16
Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues
Jack Markham, Eric Sparkes, Rochelle Boyd, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 8, pp. 1281-1295
Closed Access | Times Cited: 9
Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists
Matilda Houston, Jody Morgan, Céline Kelso
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 92-109
Closed Access | Times Cited: 5
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
Monica Patel, Natasha L. Grimsey, Samuel D. Banister, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 5
In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH‐PIATA, a new indole‐3‐acetamide synthetic cannabinoid
Caitlyn Norman, Marie H. Deventer, Olivia Dremann, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 4, pp. 380-391
Open Access | Times Cited: 4
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA
Eric Sparkes, A. J. Timmerman, Jack Markham, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1787-1812
Closed Access | Times Cited: 1
Structure–Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA
Eric Sparkes, Callan J. Maloney, Jack Markham, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 11, pp. 2160-2181
Closed Access | Times Cited: 1
Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury
Ari Misael Martínez-Torres, Julio Morán
Experimental Brain Research (2024) Vol. 242, Iss. 9, pp. 2041-2058
Open Access | Times Cited: 1
Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method
Soumajit Dutta, Diwakar Shukla
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top